| Primary |
| Panic Disorder |
50.0% |
| Acute Myocardial Infarction |
8.3% |
| Coronary Arterial Stent Insertion |
8.3% |
| Dialysis |
8.3% |
| Hypercholesterolaemia |
8.3% |
| Percutaneous Coronary Intervention |
8.3% |
| Sle Arthritis |
8.3% |
|
| Cardiovascular Disorder |
16.7% |
| Intravascular Haemolysis |
16.7% |
| Panic Disorder |
16.7% |
| Rash Maculo-papular |
16.7% |
| Sleep Disorder |
16.7% |
| Type 2 Diabetes Mellitus |
16.7% |
|
| Secondary |
| Hypertension |
33.3% |
| Drug Use For Unknown Indication |
10.6% |
| Product Used For Unknown Indication |
6.8% |
| Atrial Fibrillation |
6.4% |
| Gastritis |
4.5% |
| Hypovitaminosis |
4.5% |
| Diabetes Mellitus |
4.2% |
| Insomnia |
3.4% |
| Angina Pectoris |
3.0% |
| Hyperphosphataemia |
3.0% |
| Hypertrophic Cardiomyopathy |
3.0% |
| Colon Cancer |
2.3% |
| Nasopharyngitis |
2.3% |
| Cerebral Infarction |
1.9% |
| Essential Hypertension |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Hyperlipidaemia |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Arteriosclerosis Obliterans |
1.5% |
| Cardiac Failure |
1.5% |
|
| Hypotension |
13.6% |
| Interstitial Lung Disease |
13.6% |
| Transaminases Increased |
10.2% |
| Thrombocytopenic Purpura |
6.8% |
| Nasopharyngitis |
5.1% |
| Proteinuria |
5.1% |
| Syncope |
5.1% |
| Cytolytic Hepatitis |
3.4% |
| Dermatomyositis |
3.4% |
| Dizziness |
3.4% |
| Drug Interaction |
3.4% |
| Femur Fracture |
3.4% |
| Intravascular Haemolysis |
3.4% |
| Malaise |
3.4% |
| Myalgia |
3.4% |
| Peritonitis |
3.4% |
| Stevens-johnson Syndrome |
3.4% |
| Toxic Skin Eruption |
3.4% |
| Anaemia |
1.7% |
| Chest Pain |
1.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.5% |
| Hypertension |
25.9% |
| Product Used For Unknown Indication |
6.8% |
| Prophylaxis |
5.9% |
| Rheumatoid Arthritis |
4.7% |
| Atrial Fibrillation |
3.9% |
| Diabetes Mellitus |
2.5% |
| Prophylaxis Against Renal Transplant Rejection |
2.2% |
| Acute Myocardial Infarction |
2.2% |
| Pain |
2.1% |
| Thrombosis Prophylaxis |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
| Arrhythmia |
1.7% |
| Constipation |
1.7% |
| Hyperlipidaemia |
1.7% |
| Non-small Cell Lung Cancer |
1.7% |
| Prostate Cancer |
1.6% |
| Angina Pectoris |
1.6% |
| Cardiac Failure |
1.3% |
| Insomnia |
1.3% |
|
| Renal Failure Acute |
9.7% |
| Pyrexia |
9.1% |
| Thrombocytopenia |
8.5% |
| Vomiting |
7.4% |
| Renal Failure |
6.3% |
| Weight Decreased |
6.3% |
| Myocardial Infarction |
5.1% |
| Sepsis |
5.1% |
| Thrombosis |
4.5% |
| Weight Increased |
4.5% |
| Angioedema |
4.0% |
| Renal Impairment |
4.0% |
| Urinary Tract Infection |
4.0% |
| Acute Myocardial Infarction |
3.4% |
| International Normalised Ratio Increased |
3.4% |
| Syncope |
3.4% |
| Cytolytic Hepatitis |
2.8% |
| Epididymitis |
2.8% |
| Nervous System Disorder |
2.8% |
| Overdose |
2.8% |
|
| Interacting |
| Drug Use For Unknown Indication |
41.2% |
| Product Used For Unknown Indication |
26.5% |
| Prophylaxis Against Hiv Infection |
17.6% |
| Hypertension |
14.7% |
|
| Hypotension |
38.5% |
| Traumatic Brain Injury |
30.8% |
| Atrioventricular Block Complete |
15.4% |
| Orthostatic Hypotension |
7.7% |
| Syncope |
7.7% |
|
